Now under Balchem, Kappa Bioscience to exhibit at Vitafoods 2023
The company will demonstrate its synergies with other ingredients in Balchem’s portfolio.
Following its acquisition by Balchem Human Nutrition & Health, vitamin K2 supplier Kappa Bioscience (Oslo, Norway) will be an exhibitor at the Vitafoods Europe trade show taking place in Geneva, Switzerland, on May 9-12, at Booth J80. The company will demonstrate its synergies with other ingredients in Balchem’s portfolio.
For instance, Kappa will highlight how its K2Vital Delta double-encapsulated vitamin K2 MK-7 ingredient can pair with Balchem’s Albion Minerals organic mineral amino acid chelates to create opportunities in cardiovascular and bone health. The company touts K2Vital Delta as “the world’s only patented microencapsulated vitamin K2 preparation, which is optimally stable [and] supported in over 400 tests for mineral formulations.”
Other flagship ingredients from Balchem that will be on display at Vitafoods are OptiMSM methylsufonylmethane for joint health, beauty-from-within, and exercise recovery; and VitaCholine, a choline ingredient supporting brain function, normal lipid and homocysteine metabolism, liver function, and prenatal and infant health.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
